These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 4729604

  • 1. On the mechanism of midtrimester abortions induced by prostaglandin "impact".
    Saldana L, Schulman H, Yang WH.
    Prostaglandins; 1973 Jun; 3(6):847-58. PubMed ID: 4729604
    [Abstract] [Full Text] [Related]

  • 2. Mid-trimester abortion with 15 (S) methyl prostaglandin F 2 alpha.
    Leibman T, Saldana L, Schulman H, Cunningham MA, Randolph G.
    Prostaglandins; 1974 Sep 10; 7(5):443-8. PubMed ID: 4424912
    [Abstract] [Full Text] [Related]

  • 3. Massive initial prostaglandin impact in postconceptional therapy.
    Csapo AI, Kivikoski A, Wiest WG.
    Prostaglandins; 1972 Aug 10; 2(2):125-34. PubMed ID: 4653230
    [Abstract] [Full Text] [Related]

  • 4. Midtrimester abortion induced by single intra-amniotic instillation of two dose schedules of 15(S)-15-methyl-prostaglandin F2alpha.
    Lauersen NH, Wilson KH.
    Prostaglandins; 1975 Apr 10; 9(4):617-25. PubMed ID: 1153812
    [Abstract] [Full Text] [Related]

  • 5. Induction of therapeutic abortion using either extra-amniotic prostaglandin F-2-alpha or hypertonic saline followed by oxytocin.
    Lange AP, Secher NJ, Pedersen GT.
    Prostaglandins; 1974 Apr 25; 6(2):149-57. PubMed ID: 4847514
    [Abstract] [Full Text] [Related]

  • 6. Intra-amniotic prostaglandin F2 alpha to induce midtrimester abortion.
    Corson SL, Bolognese RJ, Merola J.
    Am J Obstet Gynecol; 1973 Sep 01; 117(1):27-34. PubMed ID: 4722375
    [Abstract] [Full Text] [Related]

  • 7. The effect of luteectomy-induced progesterone-withdrawal on the oxytocin and prostaglandin response of the first trimester pregnant human uterus.
    Csapo AI, Pulkkinen MO, Kaihola HL.
    Prostaglandins; 1973 Sep 01; 4(3):421-9. PubMed ID: 4783575
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The efficacy and acceptability of intravenously administered prostaglandin F as an abortifacient.
    Csapo AI, Sauvage JP, Wiest WG.
    Am J Obstet Gynecol; 1971 Dec 15; 111(8):1059-63. PubMed ID: 5129560
    [Abstract] [Full Text] [Related]

  • 15. Midtrimester intra-aminotic administration of prostaglandin F2alpha in combination with an hyperosmolar urea solution: effect upon plasma levels of estradiol, progesterone, and human placental lactogen (HPL).
    Sher G, Katz M.
    Acta Obstet Gynecol Scand; 1978 Dec 15; 57(3):223-5. PubMed ID: 665164
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effect of a 10 cm2, 0.5% 15-ME-PGF2alpha methyl ester intravaginal silastic device on abortion and plasma prostaglandin concentration.
    Lauersen NH, Wilson KH.
    Prostaglandins; 1977 Apr 15; 13(4):755-62. PubMed ID: 857275
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.